Soligenix is enrolling patients in its FLASH2 study, with a formal interim analysis anticipated early in 2026. <li /> SNGX's HyBryte is a ...

Improved DL-PDT Effectiveness: CAL pre-treatment boosted the therapeutic impact of daylight photodynamic therapy (DL-PDT) for ...

The global light therapy market is on an upward trajectory, projected to reach USD 1,012.1 million by 2024, and is anticipated to grow at a CAGR of 4.6% from 2024 to 2034, reaching an impressive USD 1 ...

Scientists are working to create a new light-activated 'smart' bomb to treat aggressive breast cancer. The new light-sensitive chemicals called cyanine-carborane salts are used in photodynamic therapy ...

“Our innovative cyanine-carborane salts offer a targeted option with reduced side effects for patients with aggressive breast ...

A wife and husband professor team at Michigan State University are collaborating with researchers at the University of California, Riverside to create a new light-activated “smart” bomb to treat ...

With the increase in antibiotic resistance worldwide, light-induced phototherapies, including photodynamic and photothermal therapy, have attracted interest due to their unique mode of action.

Bringing the beauty industry its Skintuition® philosophy and a first-of-its-kind photodynamic toner PHOENIX, AZ / ACCESS ...

Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a recent Zacks Small-Cap Research repor ...

A DNA nanomachine selectively targets skin cancer by detecting microRNA-7, activating phototherapy and releasing chemotherapy ...

AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical ...

Biofrontera Inc. (NASDAQ: BFRI) Q4 2024 Earnings Call Transcript March 21, 2025 Biofrontera Inc. misses on earnings ...